# IMMGOLIS
> **BLA761452** · Biologics License Application · Sponsor: ACCORD BIOPHARMA INC. · Approved 2026-05-15
## Drug
- **FDA Application Number:** BLA761452
- **Application type:** Biologics License Application
- **Brand name:** IMMGOLIS
- **Generic name:** Golimumab-Sldi
- **Active ingredients:** GOLIMUMAB-SLDI
- **Dosage form:** INJECTION
- **Route:** SOLUTION
- **Marketing status:** Prescription
- **Sponsor:** ACCORD BIOPHARMA INC.
- **First approval:** 2026-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761452)
---
*MORVS · CC0 1.0*